Patrick Aisher

Patrick Aisher is a seasoned investment professional currently serving as Director at CEBINA Bridge Capital, where the focus is on achieving absolute returns through investments in pharmaceutical drug discovery and biotech projects in Central and Eastern Europe. Aisher also holds multiple roles including Investor at Danube Labs and Director at SONECT, both dedicated to advancing life science projects and revolutionizing global payment platforms, respectively. Additional investments and directorial roles include PreComb Therapeutics AG, Araris Biotech AG, Imcheck Therapeutics, LAVA Therapeutics B.V., Vico Therapeutics B.V., and Artiria Medical, showcasing a strong commitment to innovative healthcare solutions. Aisher's educational background includes advanced degrees in finance and business administration, complemented by certifications in trust management.